Background Maternal outcomes after conservative management of placenta percreta are
poorly understood. Objective To assess the success and complication rates of conservative …

The term “morbidly adherent placenta” has recently been introduced to describe the
spectrum of disorders including placenta accreta, increta and percreta. Due to excessive …

Background The unique clinical features of pregnancy termination in the second trimester
with concurrent placenta accreta spectrum (PAS) disorders place obstetricians in a complex …

Purpose To analyse the management of patients with placenta accreta spectrum (PAS)
disorders who underwent 2 nd trimester pregnancy terminations. Method The records of …

Aim of the study: This article reports on a series of patients with placenta accreta spectrum
(PAS) disorder who were treated conservatively with Methotrexate (MTX) administration with …

AIM To evaluate the efficacy and safety of the uterine artery embolisation (UAE) in
combination with methotrexate (MTX) for conservative management of placental adhesive …

We provide recommendations for patient-centered care planning, resource requirements,
and conservative management techniques. Conservative management of PAS is a feasible …

Objectives To compare the efficacy and safety of two uterine sparing techniques in
conservative management of placenta accreta spectrum (PAS). Methods This multicenter …

Abstract Purpose of Review We review the advantages, disadvantages, and possible risks of
current therapeutic alternatives for placenta accreta spectrum (PAS). Details and proper …

Placenta accreta (PA) is a serious obstetric disorder that is characterized by deep
penetration of the villi which are abnormally attached to the myometrium of the uterus. This …